Source link : https://newshealth.biz/health-news/risankizumab-maintains-long-term-effectiveness-in-psoriasis/
TOPLINE: Risankizumab was well tolerated and demonstrated sustained effectiveness and drug survival in patients with moderate-to-severe psoriasis over a period of 4 years. Obesity, difficult-to-treat sites, and prior biologic use delayed the response, whereas bio-naive patients had faster first-year outcomes. METHODOLOGY: Researchers conducted an observational retrospective study of patients with moderate-to-severe psoriasis, with or without […]
The post Risankizumab Maintains Long-Term Effectiveness in Psoriasis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-31 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8